Moolec Science S.A. (MLEC) Research

Moolec Science S.A. is an innovative biotechnology firm specializing in the development of plant-grown animal proteins. Leveraging a transformative method called Molecular Farming, the company is poised to disrupt the alternative protein market. Their product lines and research and development efforts capitalize on the inherent agricultural benefits of select host crops, such as soybeans and peas. Globally, Moolec maintains operations across the United States, Europe, and South America. Established in 2008, the company is headquartered in Luxembourg.

Market snapshot

Symbol
MLEC
Price
$8.18
Day change
+5.41%
Market cap
$5.9M
P/E ratio
-0.03x
52-week range
3.075-120
Sector
Healthcare
Industry
Biotechnology
Analyst price target
$45.00

Peer companies

  • Dermata Therapeutics, Inc. (DRMA)
  • PMGC Holdings Inc. (ELAB)
  • Galmed Pharmaceuticals Ltd. (GLMD)
  • GT Biopharma, Inc. (GTBP)
  • NewcelX Ltd. (NCEL)
  • NKGen Biotech, Inc. Common Stock (NKGN)
  • Tivic Health Systems, Inc. (TIVC)
  • Virax Biolabs Group Limited (VRAX)

Recent insider activity

  • Core Daniel Joaquin — trade (933 shares) on 2028-06-30
  • Falottico Valeria Ines — trade (0 shares) on 2026-02-06
  • Falottico Valeria Ines — trade (2222 shares) on 2028-06-30
  • Falottico Valeria Ines — trade (2333 shares) on 2026-02-06
  • Falottico Valeria Ines — trade (2333 shares) on 2026-02-06

Open Moolec Science S.A. (MLEC) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.